Generic Drug Manufacturers to Go to the Hill Tomorrow

The Senate will hold a hearing on biogenerics tomorrow. Today's Bloomberg vignette includes sound bites with Barr Pharma CEO Bruce Downey, Representative Henry Waxman and bio lobbyist Michael Warner.

Play Video

Generic Drug Manufacturers to go to The Hill Tomorrow - Bloomberg

Bloomberg - (BLOOM)

Mar. 07, 2007. 05:24 PM EST

Biogenerics is on the agenda.

Here are latest industry lobbying figures from OpenSecrets.org. Below, the respective lobbying budgets for each side six years ago (generics' budgets have likely increased dramatically since then, just like name brands').

Lobbying Expenditures (Millions of Dollars) for Brand Name and Generic Drug Companies and their Trade Groups, 1997-2001

Drug Makers

1997

1998

1999

2000

2001

Totals

Brand-Name Drug Cos. and Trade Groups

$72.6

$69.3

$82.5

$89.0

$75.4

$388.8

Generic Drug Cos. and Trade Groups

$.8

$1.1

$1.1

$1.3

$2.4

$6.7

Totals

$73.4

$70.4

$83.6

$90.3

$77.8

$395.5

Source: Public Citizen analysis of Lobby Disclosure reports filed with the Secretary of the Senate and Clerk of the House pursuant to the Lobby Disclosure Act of 1995.